Intraoperative blood salvage in abdominal uterine myomectomy.
To study the safety and efficacy of intraoperative blood salvage in abdominal uterine myomectomy. Thirty-seven patients with a clinical diagnosis of uterine myoma who underwent abdominal uterine myomectomy were treated with an intraoperative blood salvage apparatus, Cell Saver, and compared with the patients without autotransfusion. Thirty-five patients received autologous blood transfusion alone and only two patients required additional homologous transfusion. The hemoglobin of processed and reinfused blood was proportional to the volume of intraoperative blood loss. There were no adverse reactions related to autologous transfusion. In the patients with more than 500 ml of blood loss, the mean blood loss volume in the Cell Saver group was higher than that in the control group, and the postoperative hemoglobin level was also higher. Intraoperative blood salvage was safe and certainly promising for patients with heavy blood loss during abdominal uterine myomectomy.